Table 1.
WBRT + boost | WBRT Alone | SRS Alone | P Value | |
---|---|---|---|---|
(n = 79) | (n = 140) | (n = 44) | ||
Age, No. (%) | 0.563 | |||
< 60 | 36 | 67 | 17 | |
≥60 | 43 | 73 | 27 | |
Sex, No. (%) | 0.819 | |||
Male | 55 | 103 | 32 | |
Female | 24 | 37 | 12 | |
KPS, No. (%) | 0.931 | |||
≤80 | 47 | 84 | 25 | |
> 80 | 32 | 56 | 19 | |
Number of BMs, No. (%) | < 0.001 | |||
1–3 | 51 | 34 | 39 | |
> 3 | 28 | 106 | 5 | |
Maximum size of BM, No. (%) | 0.170 | |||
< 20 mm | 36 | 81 | 26 | |
≧20 mm | 43 | 59 | 18 | |
Extracranial metastases, No. (%) | 0.009 | |||
Yes | 17 | 53 | 6 | |
None | 14 | 20 | 6 | |
Unknown | 48 | 67 | 32 | |
Symptoms of BM, No. (%) | 0.123 | |||
Yes | 37 | 69 | 14 | |
None | 42 | 71 | 30 | |
Systematic treatment | 0.833 | |||
CTx | 55 | 99 | 29 | |
No-CTx | 24 | 41 | 15 |
Abbreviations: WBRT+boost whole brain radiotherapy plus focal radiation boost, WBRT whole brain radiation therapy, SRS stereotactic radiosurgery, KPS Karnofsky Performance Status, BM brain metastasis, CTx chemotherapy, No-CTx no chemotherapy